IP Library › Assignment 031384/0805
Patent Assignment
Reel/Frame 031384/0805

Assignment of Assignor's Interest

Recorded: 2013-10-10 Pages: 12
Assignors
ANDERSON, KENNETH C.
Executed: 2013-10-07
CHAUHAN, DHARMINDER
Executed: 2013-10-07
Assignee
DANA-FARBER CANCER INSTITUTE, INC.
450 BROOKLINE AVENUE, BOSTON, MASSACHUSETTS, 02215-5450
Covered Property (1)
Compositions and Methods for Treating Neoplastic Diseases
Patent: 8,722,724 →
Application: 12/183,007 →
Publication: US 2009/0036390
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 17, 2012
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028618/0850 →
Assignment of Assignor's Interest Jul 17, 2012
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028618/0860 →
Assignment of Assignor's Interest Jun 24, 2013
From: NEREUS PHARMACEUTICALS, INC.
To: TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
Reel/Frame 030670/0412 →
Assignment of Assignor's Interest Feb 13, 2017
From: NEREUS PHARMACEUTICALS, INC.
To: TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
Reel/Frame 041698/0404 →
Assignment of Assignor's Interest Jun 11, 2018
From: 1096271 B.C. UNLIMITED LIABILITY COMPANY
To: CELGENE TRI A HOLDINGS LTD.
Reel/Frame 046047/0177 →
Assignment of Assignor's Interest Jun 11, 2018
From: CELGENE RESEARCH AND DEVELOPMENT I ULC, FORMERLY KNOWN AS TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
To: 1096271 B.C. UNLIMITED LIABILITY COMPANY
Reel/Frame 046047/0201 →
Assignment of Assignor's Interest Feb 6, 2020
From: CELGENE TRI A HOLDINGS LTD.
To: CELGENE INTERNATIONAL II SARL
Reel/Frame 051741/0848 →